Holtrop M E, Raisz L G
Calcif Tissue Int. 1979;29(3):201-5. doi: 10.1007/BF02408081.
The effects of 1,25-dihydroxy vitamin D3 [1,25(OH)2D3], prostaglandin (PGE2), and osteoclast-activating factor (OAF) on the size of osteoclasts, nuclei, ruffled borders, and clear zones in cultured long bones of fetal rats were quantitated. In addition, the number of osteoclasts in the bones was counted and the release of calcium from the bone into the culture medium was determined. These data were compared with the corresponding effects of parathyroid hormone (PTH). All agents tested increased the size of the ruffled borders significantly after 3 h, the size of the clear zones after 12 h, and the size of the cells after 12-24 h. No important differences in sizes were noticed between the agents tested or between the agents and PTH. The number of osteoclasts was increased after 24 h of treatment with PTH, but not after the other agents. Calcium release was significantly increased for all agents between 12 and 24 h. It is concluded that bone resorption by 1,25(OH)2D3, OAF, and PGE2 is mediated primarily by increased activity of existing osteoclasts similar to PTH activation.
对1,25 - 二羟基维生素D3 [1,25(OH)2D3]、前列腺素(PGE2)和破骨细胞激活因子(OAF)对胎鼠培养长骨中破骨细胞大小、细胞核、皱褶缘和清亮区的影响进行了定量分析。此外,还对骨中破骨细胞的数量进行了计数,并测定了骨中钙释放到培养基中的量。将这些数据与甲状旁腺激素(PTH)的相应作用进行了比较。所有测试药物在3小时后均显著增加了皱褶缘的大小,12小时后增加了清亮区的大小,12 - 24小时后增加了细胞的大小。在所测试的药物之间或药物与PTH之间,在大小方面未发现重要差异。用PTH处理24小时后破骨细胞数量增加,但其他药物处理后未增加。所有药物在12至24小时之间钙释放均显著增加。结论是,1,25(OH)2D3、OAF和PGE2引起的骨吸收主要是通过现有破骨细胞活性增加介导的,类似于PTH激活。